GlobeNewswire Inc.··AlvotechAlvotech Advances Biosimilar Pipeline With Five Marketed Products, Nine In Development
Alvotech files 2025 annual SEC report with five marketed biosimilars and nine pipeline candidates supported by global partnerships.
ALVOALVOWForm 20-FSEC filing